Hsbc Holdings PLC Increases Position in Sabra Healthcare REIT, Inc. $SBRA

Hsbc Holdings PLC increased its holdings in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 19.7% in the 4th quarter, HoldingsChannel.com reports. The fund owned 514,409 shares of the real estate investment trust’s stock after buying an additional 84,784 shares during the period. Hsbc Holdings PLC’s holdings in Sabra Healthcare REIT were worth $9,738,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently modified their holdings of the business. Focus Partners Wealth lifted its holdings in Sabra Healthcare REIT by 11.4% during the first quarter. Focus Partners Wealth now owns 23,146 shares of the real estate investment trust’s stock worth $404,000 after acquiring an additional 2,375 shares during the period. EverSource Wealth Advisors LLC grew its stake in Sabra Healthcare REIT by 150.7% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,555 shares of the real estate investment trust’s stock valued at $47,000 after purchasing an additional 1,536 shares during the period. First Trust Advisors LP increased its position in shares of Sabra Healthcare REIT by 27.2% during the 2nd quarter. First Trust Advisors LP now owns 368,383 shares of the real estate investment trust’s stock valued at $6,793,000 after purchasing an additional 78,709 shares during the last quarter. Cerity Partners LLC increased its position in shares of Sabra Healthcare REIT by 73.0% during the 2nd quarter. Cerity Partners LLC now owns 18,686 shares of the real estate investment trust’s stock valued at $345,000 after purchasing an additional 7,885 shares during the last quarter. Finally, Daiwa Securities Group Inc. raised its stake in shares of Sabra Healthcare REIT by 3.1% during the 2nd quarter. Daiwa Securities Group Inc. now owns 83,889 shares of the real estate investment trust’s stock worth $1,547,000 after purchasing an additional 2,557 shares during the period. 99.40% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities analysts recently weighed in on the stock. Raymond James Financial initiated coverage on shares of Sabra Healthcare REIT in a research report on Wednesday, June 17th. They set an “underperform” rating for the company. Wells Fargo & Company boosted their target price on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the company an “overweight” rating in a research note on Monday, June 1st. Cantor Fitzgerald increased their target price on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “neutral” rating in a research report on Monday, May 11th. Weiss Ratings cut shares of Sabra Healthcare REIT from a “buy (b+)” rating to a “buy (b)” rating in a report on Thursday, June 4th. Finally, Wall Street Zen downgraded Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a research note on Saturday, June 20th. Four analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Sabra Healthcare REIT presently has a consensus rating of “Hold” and a consensus price target of $21.30.

Sabra Healthcare REIT Stock Performance

Sabra Healthcare REIT stock opened at $19.54 on Friday. The firm has a market capitalization of $4.93 billion, a PE ratio of 31.02, a price-to-earnings-growth ratio of 1.44 and a beta of 0.64. The company has a current ratio of 4.72, a quick ratio of 4.72 and a debt-to-equity ratio of 0.96. The firm’s 50 day simple moving average is $19.76 and its 200 day simple moving average is $19.64. Sabra Healthcare REIT, Inc. has a 1-year low of $17.17 and a 1-year high of $21.28.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 EPS for the quarter, meeting analysts’ consensus estimates of $0.16. The business had revenue of $211.74 million for the quarter, compared to analysts’ expectations of $209.20 million. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.The firm’s revenue was up 20.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.37 earnings per share. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. As a group, analysts expect that Sabra Healthcare REIT, Inc. will post 1.5 earnings per share for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, May 29th. Stockholders of record on Friday, May 15th were paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.1%. The ex-dividend date was Friday, May 15th. Sabra Healthcare REIT’s dividend payout ratio (DPR) is presently 190.48%.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net?lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long?term, triple?net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post?acute rehabilitation and research and development laboratories.